BIOMAT Database Logo BIOMAT Database Logo

Hepatic clearances of antipyrine, indocyanine green, and galactose in normal subjects and in patients with chronic liver diseases. 1988

S Kawasaki, and Y Sugiyama, and T Iga, and M Hanano, and T Beppu, and M Sugiura, and K Sanjo, and Y Idezuki
Second Department of Surgery, Faculty of Medicine, University of Tokyo, Japan.

Blood clearance of antipyrine, indocyanine green, and galactose were measured to evaluate the alterations of effective hepatic blood flow and hepatic intrinsic clearances in chronic liver diseases. Galactose blood clearance, which may be taken as effective hepatic blood flow, decreased by approximately 30% in patients with cirrhosis (12.49 +/- 0.76 ml/min/kg; mean +/- SE; n = 17) compared with normal subjects (18.17 +/- 1.03 ml/min/kg; n = 5). In patients with cirrhosis, intrinsic clearances of antipyrine (0.178 +/- 0.014 ml/min/kg; n = 17) and indocyanine green (6.19 +/- 1.38 ml/min/kg; n = 7) showed 61% and 85% reduction, respectively, compared with those of normal subjects (0.462 +/- 0.048 ml/min/kg; n = 5; 41.72 +/- 7.75 ml/min/kg; n = 5). Considering that indocyanine green and antipyrine are eliminated by different hepatic mechanism, these mechanisms may not be equally sensitive to decrements in hepatic function. In addition, fractional reductions of intrinsic clearances for these compounds are thus much greater than that of effective hepatic blood flow.

UI MeSH Term Description Entries
D007208 Indocyanine Green A tricarbocyanine dye that is used diagnostically in liver function tests and to determine blood volume and cardiac output. Cardio-Green,Cardiogreen,Ujoveridin,Vofaverdin,Vophaverdin,Wofaverdin,Cardio Green,Green, Indocyanine
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008102 Liver Circulation The circulation of BLOOD through the LIVER. Hepatic Circulation,Circulation, Liver,Circulation, Hepatic
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females

Related Publications

S Kawasaki, and Y Sugiyama, and T Iga, and M Hanano, and T Beppu, and M Sugiura, and K Sanjo, and Y Idezuki
[Hepatic elimination of indocyanine green and antipyrine in patients with chronic liver disease].
June 1982, Die Medizinische Welt,
S Kawasaki, and Y Sugiyama, and T Iga, and M Hanano, and T Beppu, and M Sugiura, and K Sanjo, and Y Idezuki
The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic lever disease.
July 1976, Clinical pharmacology and therapeutics,
S Kawasaki, and Y Sugiyama, and T Iga, and M Hanano, and T Beppu, and M Sugiura, and K Sanjo, and Y Idezuki
Assessment of liver function in chickens using galactose and indocyanine green clearances.
April 2000, Avian pathology : journal of the W.V.P.A,
S Kawasaki, and Y Sugiyama, and T Iga, and M Hanano, and T Beppu, and M Sugiura, and K Sanjo, and Y Idezuki
Antipyrine, oxazepam, and indocyanine green clearance in patients with chronic pancreatitis and healthy subjects.
August 1999, Scandinavian journal of gastroenterology,
S Kawasaki, and Y Sugiyama, and T Iga, and M Hanano, and T Beppu, and M Sugiura, and K Sanjo, and Y Idezuki
Indocyanine green elimination in patients with liver disease and in normal subjects.
February 1991, Clinical science (London, England : 1979),
S Kawasaki, and Y Sugiyama, and T Iga, and M Hanano, and T Beppu, and M Sugiura, and K Sanjo, and Y Idezuki
[Correlations of kinetics of antipyrine, indocyanine green and bromosulfophthalein in healthy subjects and in patients with cardiovascular diseases].
July 1978, Polski tygodnik lekarski (Warsaw, Poland : 1960),
S Kawasaki, and Y Sugiyama, and T Iga, and M Hanano, and T Beppu, and M Sugiura, and K Sanjo, and Y Idezuki
The Effects of Lansoprazole on the Disposition of Antipyrine and Indocyanine Green in Normal Human Subjects.
August 1995, American journal of therapeutics,
S Kawasaki, and Y Sugiyama, and T Iga, and M Hanano, and T Beppu, and M Sugiura, and K Sanjo, and Y Idezuki
[Liver capacity in the biotransformation of drugs in patients with chronic circulatory failure (kinetics of antipyrine and indocyanine green)].
October 1978, Polskie Archiwum Medycyny Wewnetrznej,
S Kawasaki, and Y Sugiyama, and T Iga, and M Hanano, and T Beppu, and M Sugiura, and K Sanjo, and Y Idezuki
Comparative evaluation of the effects of labetalol, verapamil and diltiazem on antipyrine and indocyanine green clearances.
October 1989, Journal of clinical pharmacology,
S Kawasaki, and Y Sugiyama, and T Iga, and M Hanano, and T Beppu, and M Sugiura, and K Sanjo, and Y Idezuki
Selective effects of a bacterial infection (Actinobacillus pleuropneumoniae) on the hepatic clearances of caffeine, antipyrine, paracetamol, and indocyanine green in the pig.
May 1995, Xenobiotica; the fate of foreign compounds in biological systems,
Copied contents to your clipboard!